[4] Similarly, SURPASS-4, which specifically enrolled patients at high cardiovascular risk, demonstrated a numerical reduction in MACE with tirzepatide compared to insulin glargine, suggesting potential cardiovascular benefit, though definitive conclusions await the dedicated outcomes trial
Some groups, such as those with higher starting BMI or certain obesity-related health conditions, may see different results
This long-term management approach is not available with phentermine
The goal is to lose body fat while maintaining muscle, strength, energy, and overall health
The group also recommended reporting the issue to the ASEAN Post-Marketing Alert System (PMAS) to alert the FDA counterpart in Thailand
Additionally, it has beneficial effects on toothaches and oral infections [50]